Skip to main content
Molecular Vision logoLink to Molecular Vision
. 2013 Jun 6;19:1258.

Withdrawal: Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells

The Editors of Molecular Vision
PMCID: PMC3675055  PMID: 23761728

Due to duplicate publication of part of Figure 1c from [1] in Figure 5 of [2], the authors of have voluntarily withdrawn their article from Molecular Vision. The corresponding author of [2] was the first to bring this error to the attention of the Editors. He did so promptly, and it was he who first sought to withdraw the article.

References

  • 1.Acharya S, Dilnawaz F, Sahoo SK. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials. 2009;30:5737–50. doi: 10.1016/j.biomaterials.2009.07.008. [DOI] [PubMed] [Google Scholar]
  • 2.Mitra M, Misra R, Harilal A, Sahoo SK, Krishnakumar S.Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells. Mol Vis 2011172724–37.Epub 2011 Oct 19 [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Molecular Vision are provided here courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China

RESOURCES